Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for All Cosmos Bio-Tech Holding Limited (4148:TWSE), powered by AI.
All Cosmos Bio-Tech Holding Limited is currently trading at $31.15. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for All Cosmos Bio-Tech Holding Limited on Alpha Lenz.
View All Cosmos Bio-Tech Holding Limited's valuation metrics on Alpha Lenz.
“All Cosmos Bio-Tech Holding Limited's ROE is 5.8%. Explore profitability and growth together.”
Ask for details →All Cosmos Bio-Tech Holding Limited is a leading company in the agribusiness sector, focusing primarily on the production and distribution of bio-based fertilisers. The company's core function is to provide high-quality, environmentally friendly fertilisers that enhance crop yield while promoting sustainable farming practices. Their products are designed to cater to the growing demand for eco-friendly agricultural inputs as global awareness of sustainable development and food security increases. Notable features of All Cosmos Bio-Tech include its commitment to research and development, which drives innovation in creating effective bio-fertilisers. The company’s operations significantly impact agricultural industries, from small-scale farms to large agribusinesses, by improving productivity and soil health. Within the financial market, All Cosmos Bio-Tech plays a vital role as a partner in the global move towards sustainability, supporting both economic growth and environmental stewardship. Its pioneering techniques and sustainable product portfolio make it a key player in the bio-tech and agri-sciences sectors.
“All Cosmos Bio-Tech Holding Limited's ROE is 5.8%. Explore profitability and growth together.”
Ask for details →All Cosmos Bio-Tech Holding Limited (ticker: 4148) is a company listed on TWSE in the Basic Materials sector (Agricultural Inputs).
The current price is 31.15 with a P/E ratio of -x and P/B of -x.
ROE is 5.82% and operating margin is 10.30%. Annual revenue is $2.9B.